Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MEF2-activating motif and SAP domain-containing transcriptional regulator (MAMSTR) is a member of the myocardin-related transcriptional coactivators that functions as a key facilitator of MEF2 (myocyte enhancer factor 2)-dependent gene expression, particularly in skeletal muscle. MAMSTR acts as a transcriptional coactivator, directly interacting with MEF2 proteins to activate muscle-specific enhancers and promote the expression of regulators such as MyoD[1][6][7]. Inhibition of MAMSTR impairs myoblast differentiation and muscle regeneration, highlighting its critical role in myogenesis and satellite cell function[1]. MAMSTR is predicted to act primarily in the nucleus, with additional roles in the broader regulation of transcription by RNA polymerase II[5]. While not a traditional therapeutic target like receptors or enzymes, MAMSTR's function in muscle biology has implications for regenerative medicine and livestock genetic traits[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MEF2-activating motif and SAP domain-containing transcriptional regulator (MAMSTR).